Dis­trict court hands Janssen a win in patent feud with Vi­a­tris

John­son & John­son’s Janssen has a new court win re­lat­ed to its an­tipsy­chot­ic drug.

A judge on Mon­day ruled that My­lan’s pro­posed la­bels for a gener­ic ver­sion of paliperi­done, Janssen’s an­tipsy­chot­ic drug, would in­fringe on one of Janssen’s patents, per an opin­ion and or­der filed in New Jer­sey Dis­trict Court. (My­lan merged with Pfiz­er’s Up­john unit in a deal that closed in late 2020 and is now called Vi­a­tris.)

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER